In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach

Entacapone, a reversible catechol-o-methyl transferase inhibitor, is used to enhance the action of dopamine agonists by reducing their metabolism and the ‘Wearing-off’ effects associated with long-term use in the treatment of Parkinson's disease. It is used as an adjunct to levodopa/Carbidopa t...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Yogeeta, Patil, Kiran, Mahajan, Hitendra, Potdar, Mrugendra, Joshi, Pratiksha, Nakhate, Kartik, Sharma, Charu, Goyal, Sameer N., Ojha, Shreesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986208/
https://www.ncbi.nlm.nih.gov/pubmed/35380091
http://dx.doi.org/10.1080/10717544.2022.2058651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986208/
https://www.ncbi.nlm.nih.gov/pubmed/35380091
http://dx.doi.org/10.1080/10717544.2022.2058651

Ejemplares similares